Borda B, Szederkényi E, Lengyel C, Morvay Z, Eller J, Marofka F, Szabó V, Takács T, Szenohradszky P, Hódi Z, Lázár G
Department of Surgery, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Transplant Proc. 2011 May;43(4):1254-8. doi: 10.1016/j.transproceed.2011.03.091.
The principal risk factors for cardiovascular mortality posttransplantation are hyperglycemia, hypertriglyceridemia, obesity, and smoking.
Among 115 patients, we assessed the risk factors for new-onset diabetes (NODM) and dyslipidemia (NODL), and their effects on the function and histopathologic changes in the allografts at 1 year posttransplantation.
When evaluating the risk factors and the initial recipient data, we observed a significant difference in age when comparing normal vs NODM patients (P=.004), normal versus NODL patients (P=.002), and normal versus NODL + NODM patients (P=.0001). The difference in body mass index (BMI) was significant when comparing normal with NODM + NODL patients (P=.003). In regard to immunosuppressive therapy, NODM was significantly more frequent among/prescribed tacrolimus (tac; P=.005), whereas subjects who received cyclosporine (CsA) showed a significantly higher incidence of NODL (P=.001). The triglyceride levels were 3.02 ± 1.51 mmol/L among those on CsA versus 2.15 ± 1.57 mmol/L for (P=.004). The difference also proved to be significant for total cholesterol level: 5.43 ± 1.23 mmol/L versus 4.42 ± 1.31 mmol/L respectively (P=.001). In regard to allograft function a significant difference was noted at 1 year after transplantation between the NODM + NODL and the normal group in serum creatinine level (P=.02) as well as the estimated glomerular filtration rate (P=.004). Among diabetic patients, the serum creatinine level measured at posttransplant year 5 was significantly higher than that in 1 year (212.43 vs 147.00 μmol/L; P=.0003). When assessing morphologic changes in the kidney, we observed significantly more frequent interstitial fibrosis/tubular atrophy in all 3 groups compared with normal function patients.
Our clinical study suggested that at 1 year after transplantation allograft function is already impaired in the presence of both medical conditions (NODM and NODL). However, in regard to morphology, a single condition (NODM or NODL) was sufficient to produce histologic changes in the kidney.
移植后心血管死亡的主要危险因素为高血糖、高甘油三酯血症、肥胖和吸烟。
在115例患者中,我们评估了新发糖尿病(NODM)和血脂异常(NODL)的危险因素,以及它们对移植后1年同种异体移植物功能和组织病理学变化的影响。
在评估危险因素和初始受者数据时,我们发现,在比较正常患者与NODM患者(P = 0.004)、正常患者与NODL患者(P = 0.002)以及正常患者与NODL + NODM患者(P = 0.0001)时,年龄存在显著差异。在比较正常患者与NODM + NODL患者时,体重指数(BMI)差异显著(P = 0.003)。在免疫抑制治疗方面,使用他克莫司(tac)的患者中NODM更为常见(P = 0.005),而接受环孢素(CsA)治疗的患者NODL发生率显著更高(P = 0.001)。CsA组患者的甘油三酯水平为3.02±1.51 mmol/L,而另一组为2.15±1.57 mmol/L(P = 0.004)。总胆固醇水平差异也具有显著性:分别为5.43±1.23 mmol/L和4.42±1.31 mmol/L(P = 0.001)。在同种异体移植物功能方面,移植后1年,NODM + NODL组与正常组在血清肌酐水平(P = 0.02)以及估计肾小球滤过率(P = 0.004)方面存在显著差异。在糖尿病患者中,移植后第5年测得的血清肌酐水平显著高于第1年(212.43对147.00 μmol/L;P = 0.0003)。在评估肾脏形态学变化时,我们观察到,与功能正常的患者相比,所有3组患者的间质纤维化/肾小管萎缩更为常见。
我们的临床研究表明,移植后1年,在同时存在这两种病症(NODM和NODL)的情况下,同种异体移植物功能已经受损。然而,在形态学方面,单一病症(NODM或NODL)就足以导致肾脏组织学变化。